Agreed Michelin . New blood can be good but the danger is that if they don't deliver the goods in an acceptable timeframe the market is quick to judge if they don't see results and or get informed regularly . It's the biggest pitfall of spec stocks as I've experienced .
With the announcement today being the feel good fluffy stuff another announcement with some positive meat on the bones within the next couple of weeks would be just what NSP needs to attract some attention . GLTA
Ann: START OF IN-VITRO CLINICAL TRIAL AT MONASH IVF, page-23
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $25.15K | 5.030M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 18776263 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 10551662 | 4 |
View Market Depth
| Last trade - 10.32am 08/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
